Patient preferences in treatment options of ulcerative colitis: a discrete choice experiment

Straatmijer, T., van den Akker-van Marle, M. E., Ponsioen, C. Y., van der Horst, D., Scherpenzeel, M. P. M., Duijvestein, M. & van der Meulen-de Jong, A. E., 2024, In: Scandinavian journal of gastroenterology. 59, 3, p. 288-295 8 p.

Research output: Contribution to journal › Article › Academic › peer-review

Effectiveness and safety of tofacitinib for ulcerative colitis: two-year results of the ICC Registry

Straatmijer, T., van Schaik, F. D. M., Bodelier, A. G. L., Visschedijk, M., de Vries, A. C., Ponsioen, C. Y., Pierik, M., van Bodegraven, A. A., West, R. L., de Boer, N. K. H., Srivastava, N., Romkens, T. E. H., Hoekstra, J., Oldenburg, B., Dijkstra, G., van der Woude, J. C., Löwenberg, M., Mujagic, Z., Biemans, V. B. C., van der Meulen-de Jong, A. E., & 1 othersDuijvestein, M., Jan 2023, In: Alimentary Pharmacology and Therapeutics. 57, 1, p. 117-126 10 p.

Research output: Contribution to journal › Article › Academic › peer-review

Inflammatoire darmziekten

Translated title of the contribution: Inflammatory bowel diseaseStraatmijer, T. & Duijvestein, M., 31 Aug 2023, In: Nederlands Tijdschrift voor Geneeskunde. 167

Research output: Contribution to journal › Article › Professional

Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in inflammatory bowel disease patients—authors' reply

Volkers, A., Straatmijer, T., Duijvestein, M., Löwenberg, M., van der Meulen, A. & D'Haens, G., 1 Mar 2023, In: Alimentary Pharmacology and Therapeutics. 57, 6, p. 743-744 2 p.

Research output: Contribution to journal › Comment/Letter to the editor › Academic